Overall, of particular interest is the accumulating evidence coming from human studies indicating reduced PPARα expression in the brains of AD patients, which is considered to be associated with the main pathological features of the disease, including neuroinflammation, impaired fatty acid transport, mitochondrial dysfunction, and decreased clearance of Aβ plaques. Here, PPARA is linked to Alzheimer disease.